The Aston Baker Cutting Edge Aesthetic Surgery Symposium will be held December 5-7, 2019 in New York City!

Co-Chairmen Sherrell J. Aston, MD and Daniel C. Baker, MD

Co-Chairmen Sherrell J. Aston, MD and Daniel C. Baker, MD

Cutting Edge 40th Anniversary

Cutting Edge 40th Anniversary

Cutting Edge Program Cover

NEW YORK CITY, NEW YORK, USA, October 31, 2019 /EINPresswire.com/ — Internationally acclaimed plastic surgeons Dr. Sherrell J. Aston and Dr. Daniel C. Baker are proud to invite you to the Aston Baker Cutting Edge Aesthetic Surgery Symposium, "Achieving Superior Results, Avoiding Complications and Managing Revisions", which will be held this December 5-7, 2019 at the Marriott Marquis in New York City.

The 2019 Symposium is a uniquely designed and innovative educational experience. Our Course Chairmen have invited an esteemed faculty of surgeon educators to present the most advanced clinical applications of established procedures and innovative new technologies for facial rejuvenation and total body sculpting.

The program features 74 Lectures, 7 Panels, 10 Point/Counterpoint Debates, 4 Surgical Video Presentations and an Open Forum with the Faculty. Attendees will see the hands-on work of our world-renowned faculty of international experts.

The lectures will be highly edited to highlight the key steps of advanced techniques for face and body rejuvenation and contouring with a focus on avoiding complications and managing revisions.

Seven panels will explore methods for facial and body rejuvenation and sculpting, comparing the complexity of procedures, technical details, longevity, complications and patient safety issues.

Ten Point/Counter Point lectures will encourage debate between faculty members on philosophy, techniques, and controversial areas.

An Open Forum with the Faculty will permit audience participation, questions and discussion. Patient safety, complications and long term results will be stressed throughout the symposium.

This activity has been planned and implemented in accordance with the Essential Areas and Elements of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society for Aesthetic Plastic Surgery,Inc. and the New York Plastic Surgery Foundation,Inc.

The American Society for Aesthetic Plastic Surgery, Inc. is accredited by the ACCME to provide continuing medical education for physicians. The American Society for Aesthetic Plastic Surgery, Inc. designates this educational activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity. Credit hours are subject to program changes.

Of the 21 credits, 8 have been identified as programming dedicated to patient safety related topics and will satisfy the Patient Safety CME requirement.

Members of the press who'd like to attend please contact us directly at 212-327-4681.

For program details and registration visit our website at www.nypsf.org. We look forward to seeing you in New York!

Bernadette McGoldrick
New York Plastic Surgery Foundation
+1 212-327-4681
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

We look forward to welcoming you to New York!


Source: EIN Presswire

Magi Helena, Acclaimed Astrologer, Explains the Truth of Mercury Retrograde Phobia

Magi Helena, Acclaimed Astrologer

Mercury goes retrograde Oct. 31. Does Mercury retrograde really turn things upside down? Maybe yes, maybe no.

LOS ANGELES, CA, UNITED STATES, October 30, 2019 /EINPresswire.com/ — Mercury goes retrograde Oct. 31. Does Mercury retrograde really turn things upside down? Maybe yes, maybe no.

While social media is full of people who are positive that the computer glitches and miscommunications they experience during Mercury retrograde are caused by Mercury retrograde, what if they’re not? Technically, Jupiter is retrograde about 3 months a year, Neptune about 5 months a year, and so on. However, nobody seems to panic during other planetary retrogrades. In fact, there is almost never one single day when one of the closest planets to Earth is NOT retrograde.

“Both western astrology tradition and Science-Based Astrology research agree that Mercury rules thinking, quick wits, self-expression and communications of all kinds including acting and co-rulership of singing, and travel,” explains Magi Helena, acclaimed astrologer. “If Mercury retrograde caused problems with these areas, we would expect to see that people, companies, and products which were ‘born’ during Mercury retrograde would have Mercury ‘problems’. However, it’s actually the opposite!”

Celebrities ‘born’ during Mercury retrograde include: Adam Levine, Anna Kendrick, Ben Affleck, Ben Stiller, George Lucas, Hugh Jackman, Jeff Bezos, Julia Roberts, Justin Bieber, Madonna, Michael Jackson, Rihanna, Selena Gomez, Sir Paul McCartney, Tina Fey. Mercury retrograde companies include Facebook, General Motors, Mercedes-Benz, Microsoft, PayPal, Twitter, UPS, and Verizon.

“All these people and companies are especially talented and successful in Mercury-ruled fields and all have Mercury retrograde. So how could Mercury retrograde really be a kiss of death in these areas of life?” asks Magi Helena. “Mercury retrograde has never been proven to be detrimental. In actual fact, statistical research has proven conclusively that planets in retrograde can actually be MORE powerful and helpful in charts than direct planets. Not always, but most of the time.”

According to Magi Helena, if someone really wants to use the power of the stars to achieve love and success and avoid heartbreak and failure, they will also need to use their own personal cycles to discover when their best windows of opportunity will open, and when challenges and obstacles are more likely. (https://magihelena.com/personal-astrology-calendars/)

If someone is curious to see if Mercury retrograde really causes day-to-day frustrations and problems, they should keep track over a period of time of glitches and miscommunications during Mercury retrograde vs. Mercury direct. Doing so for a year or more will give an accurate sampling. They’ll be more likely to find a higher correlation between day-to-day problems and Universal Worst Days found here, (https://magihelena.com/magi-best-worst-days/) than they are to find correlations between problems and Mercury retrograde.

“In Science-Based Astrology we use 6 dimensions of calculation,” concludes Magi Helena. “In the 3 Geocentric dimensions, retrogrades occur. In the 3 Heliocentric dimensions, there are no retrogrades. For accurate answers, we use 20 – 30 or more planets, asteroids and midpoints in all 6 dimensions. A particular planet in retrograde seems far less important seen against this enormous backdrop. The Universal quality of a day, your personal progressions and transits, and careful selection of crucial natalization dates are FAR more important than unsubstantiated retrograde-phobia.”

Aurora DeRose
Michael Levine Media
+1 310-396-6090
email us here


Source: EIN Presswire

World largest Civil Cargo Drone Premiere by Singular Aircraft

Portrait of Singular Aircraft Drone in Lleida airport in cloudy day

Singular Aircraft Drone

Singular Aircraft is demonstrating the world largest civil cargo drone in Dominican Republic this November as a World Premiere.

SPAIN, October 29, 2019 /EINPresswire.com/ — Singular Aircraft has been performing flight demonstrations of the brand's flagship, fully autonomous UAV Flyox I in Barahona, Dominican Republic, over the span of 8 days.

Singular Aircraft´s Flyox I is the only amphibious UAV in the world designed for civil purposes of 4,000 KG of Maximum Take Of Weight (MTOW), with speed ranges from 75 to 140Kts. Therefore, demonstrations were part Visual Line Of Sight and part Beyond Visual Line Of Sight in the airport CTR and the segregated area provided.

It has been a total of 8 flights, more than 3,000 Km flown, during more than 20 flight hours. All of which, were fully autonomous operations that were demonstrating different configurations, speeds and manoeuvres using the standard cargo version of this model.

All the flight operations were combined with other planes and helicopters that were using the same airspace and ground control from the tower of Barahona International Airport and from Santo Domingo FIR, with several de-conflicting manoeuvres performed in each and every flight.

The aircraft has performed its flights spectacularly, even when put under unusual weather conditions, as during these operations, the north of the island was hit by hurricane Lorenzo and some of the flights were carried through windy conditions (+30kts) and heavy rain showers.

Video footage & Plane Photographs

For more information and contact: www.singularaircraft.com

NEXT DEMONSTRATIONS

The next flight demonstrations for the Flyox UAV cargo version together with a conference on UAV's in Santo Domingo are scheduled to take place from November 22nd to December 4th.

The Air Drop version will be showcased early next year and the Surveillance version will also be showcased in mid 2020.

ABOUT THE AIRCRAFT

Singular Aircraft has designed and is producing the biggest amphibious civil UAV in the market with 5 different configurations: Cargo, Air Drop, Crop Spraying, Firefighting and Surveillance.
The main characteristics are:
• MTOW: 4.000Kg
• Payload: 1,850 Kg
• Endurance: from 6hrs to 30hrs for surveillance
• Twin Engine: 2x360Hp regular 95 octane fuel
• Retractable tail grader Landing Gear
• Lowest direct operational cost in the market
• Fully Autonomous operation (Take 0ff, Climb, Cruise, Approach, Landing)
• Fits in standard 40’ HC maritime container
• Fully customisable
• Take Off and landing on unprepared runways & water

Due to it’s size and capacity the plane is capable to perform many operations that were not possible with other platforms.
Examples of these operations are:

The Cargo version transports to/from runways or lakes any goods aiding logistics and delivers liquids, bulk goods, boxes, etc. at an unbeatable cost.
Eg: autonomous transport of 1.000Kg to 1.000Km from 1.000USD DOC.

The Air Drop version has been designed for humanitarian relief and resupply of remote operations and regions where a runway is not an option and has the capability of delivering up to 1,500kg of goods with a parachute to isolated communities, islands, mining operations, ships, offshore platforms, etc.
Eg: autonomous transport & delivery 1.000Kg to 500Km (1.000Km round trip)

The Crop Spraying plane can spray chemicals, or fertilizers and even seeds from the air. Ej: 16L/Ha conc. We cover 100Ha/h at 2,5USD/Ha DOC.

The Firefighting version is capable of precision water bombing without risking crew’s lives with 24hrs operation (day and night) increasing the efficiency of firefighting operations substantially with fleet operations.
Eg: delivering 30.000 L/h of water for each fire flank.

The Surveillance version has more than 30 hours of endurance whilst carrying 350Kg of radars, electro optics, communication equipment and several other sensors and onboard computers.
Eg: Maritime Exclusive Economic Zone surveillance of 1.000.000 sqKm / flight through Radar, AIS & optical gimbals.

Luis Carrillo
Singular Aircraft
+34 629 40 89 82
email us here

World Premiere Cargo Drone Show in Barahona International Airport Dominican Republic


Source: EIN Presswire

Rosa and Co.’s Dr. Christina Friedrich to present the power of QSP modeling at the AAPS Annual Meeting

Image to explain how PhysioPD Research improves understanding of how drug activity influences clinical outcomes

PhysioPD Research reduces risk by improving understanding of how drug activity influences clinical outcomes

Rosa & Co. logo

Photo of Mike Reed

Case studies show how PhysioPD™ Research saves time and money, and provides critical information when a clinical trial is not an option.

PhysioPD Research delivers significant insights when a clinical trial is not a possibility,”

— Christina Friedrich, Chief Engineer, Rosa & Co.

SAN CARLOS, CA, USA, October 29, 2019 /EINPresswire.com/ — Rosa & Co’s Chief Engineer Christina Friedrich, PhD, will present two key case studies at the 2019 American Association of Pharmaceutical Scientists Annual Meeting, AAPS PharmSci 360, taking place November 3-6 in San Antonio, Texas.

“We are excited to present the conclusions of two case studies at a premier event such as AAPS PharmaSci 360,” said Christina Friedrich, Rosa & Co’s Chief Engineer. “Our results reveal how PhysioPD Research reduces risk and increases confidence in drug development as well as delivers significant insights when a clinical trial is not a possibility, as is the case for analyzing outcomes of intervention after an opioid overdose.”

In a presentation entitled "How does QSP Modeling Support R&D Decisions? Case examples of modeling impact in the central nervous system and inflammatory diseases", Dr. Friedrich will discuss results focused on psoriasis drug development as well as intervention after an opioid overdose. In both projects, PhysioPD Research – Rosa’s brand of QSP modeling – increased confidence to develop successful clinical trials and product submissions through an improved understanding of how drug mechanisms influence clinical outcomes.

The first project utilized PhysioPD Research to elucidate the value of novel psoriasis therapies as well as identify mechanistic drivers of response. Impact on development included shortening of a psoriasis clinical trial, and associated time and money savings. Importantly, this project sheds light on when a novel drug may not be sufficiently effective. The results further provided suggestions of key experiments to test these assumptions as well as helped clarify the types of patients that may be the strongest responders.

The second project demonstrated the efficacy of higher-dose naloxone, an opioid receptor antagonist used to treat opioid overdose, without a clinical trial. PhysioPD Research was used to evaluate the effect of naloxone on mu opioid receptor occupancy under a range of assumptions. Notably, Rosa’s modeling predicted the efficacy of higher-dose naloxone in preventing deaths from an opioid overdose, providing valuable supporting information for regulatory submission in a situation where a clinical trial is not an option. The evidence obtained through this project is currently being used for conversations with regulators and to potentially save time, money, and lives by bringing a higher-dose naloxone product to the market efficiently.

Important lessons from these two projects include:

1) The importance of PhysioPD Research for integrating mechanistic and clinical data to investigate new targets, compounds, or protocols

2) The power of models to reproduce clinical data mechanistically thereby increasing confidence in informed extrapolation to new scenarios

3) The need for modeling transparency and stakeholder involvement for QSP outcomes.

About Rosa & Co.

Established in 2002, Rosa & Co. is known worldwide for clarifying the connection between disease mechanisms, therapeutic interventions, and clinical outcomes through its PhysioPD™ Research Platforms. The credible scientific insights and actionable program impact delivered by PhysioPD Research would be difficult or impossible to achieve with any other research approach. For more information: www.rosaandco.com

Patrick van der Valk
Rosa & Co. LLC
+1 415-692-5258
email us here
Visit us on social media:
Twitter
LinkedIn

Rosa & Co – Drug Development Advisors


Source: EIN Presswire

Exclusive interview with conference speaker Che Connon released ahead of SMi’s Ophthalmic Drugs Conference

Ophthalmic Drugs Conference 2019

Ophthalmic Drugs Conference 2019

SMi has released an exclusive interview with Che Connon, Professor of Tissue Engineering at Newcastle University, ahead of upcoming Ophthalmic Drugs conference.

LONDON, UNITED KINGDOM, October 29, 2019 /EINPresswire.com/ — As Europe’s leading Ophthalmic Drugs conference, this year’s event will explore new discoveries in the treatment of ocular rare disease, innovations in gene therapy, the challenges in drug delivery through a complex barrier, patient comfort, and regulatory compliance which make up such core components within the Ophthalmic Drug domain.

Professor Connon’s research team seeks to engineer functional replacement and temporary 'bridge' tissues using a modular approach while also developing model systems to study physiological and pathophysiological corneal tissue formation. He is currently working with smart (cell responsive) biomaterials, characterizing the mechanical and geometric environment of the corneal stem cell niche and 3D printing the corneal stroma.

Here is a snapshot of what was discussed:

The ophthalmic drugs market has matured greatly over recent years, what are the key significant developments you have noticed over the past year?
“Significant developments I have noticed include self-therapy for the cornea. The advances in cell therapy for corneal limbal stem cell treatment have been particularly significant with the fact that it has authorisation and is pushing ahead.”

What do you personally see as the greatest challenge to overcome in the field of Ophthalmic Drugs at the moment?
“My interest is in cell therapy – cellular drugs, cells as a drug and how do you list significant challenges in and around the logistics of moving that product around. Also, in the future how do you make enough cells to address all the predicted needs and patients.”

The full version of the interview and event brochure are available to download online at:
www.ophthalmicdrugs.com/PRcom9

Che Connon will be presenting on “Biomechanical modulation therapy: A druggable alternative to corneal stem cell transplantation.”
• Chemical burns to the ocular surface affect tissue stiffness
• The corneal stem cell niche has specific biomechanical requirements to retain stem cells
• Restoring the correct biomechanical state of the corneal stem cell niche following wounding improve healing
• Biomechanical modulation therapy is a new treatment paradigm for corneal epithelial wounds

Ophthalmic Drugs 2019
Main Conference: 19th – 20th November 2019
Pre-Conference Focus Day: 18th November 2019
Location: Copthorne Tara Hotel, London, UK

—END—

For sponsorship, exhibition and branding enquiries contact Alia Malick +44 (0)20 7827 6168 / amalick@smi-online.co.uk

For all media enquiries contact Neill Howard +44 (0) 207 827 6164 / nhoward@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Neill Howard
SMi Group Ltd
+44 2078276000
email us here


Source: EIN Presswire

Insight into the Latest Developments in Oligonucleotide Delivery Systems

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

SMi Reports: A Focus Day has been added to SMi’s RNA Therapeutics Conference, which will highlight recent developments in "Oligonucleotide Delivery Systems."

LONDON, UNITED KINGDOM, October 29, 2019 /EINPresswire.com/ — SMi Group are proud to present the new RNA Therapeutics Focus Day – Oligonucleotide Delivery Systems. The Focus Day will be held on the 18th of February 2020 and will present sessions that showcase a myriad of delivery approaches such as: optimising nanoparticle delivery to treat cancer and fibrosis; a review of common NA-LNP tolerability concerns to improve safety of nucleic acid therapeutics and the utility of light-triggered liposomes for retinal delivery.

In addition to this, delegates will have the opportunity to network with Global Product Managers, Heads of Drug Development, Senior Directors, Heads of Research and Development and many more.

As the only RNA therapeutics conference to dedicate a focus day to exploring developments and innovations in oligonucleotide delivery systems, the Oligonucleotide Delivery Systems Focus Day is a key diary date for those in the industry.

An early bird savings of £400 is available to those who register by 31st October. Register now at: www.therapeutics-rna.com/EINPR3

Focus Day Highlights:
Optimising Nanoparticle mediated delivery of siRNAs to treat cancer and fibrosis
• Presenting a polypeptide nanoparticle mediated delivery system for siRNA therapeutics to treat cancer and fibrosis
• The benefits of the ability to deliver multiple siRNAs within the tumour microenvironment
• Leveraging this capability to improve outcomes with Immune Checkpoint inhibitors
• Improved GMP manufacturing approaches using microfluidics for clinical development
David Evans, CSO, Sirnaomics

Addressing the challenge of chronic dosing via traditional LNPbased delivery for mRNA therapeutics
• Clinical appeal of lipid nanoparticle delivery systems and other competing modes of delivery
• Challenges in production and screening of LNP candidates for effective translation to biotherapeutics
• Complications of chronic dosing and acceptable tolerability profiles
• Showcasing the development of a tolerable subcutaneous administration of mRNA via functionalised LNPs
Shalini Andersson, Chief Scientist New Therapeutic Modalities, AstraZeneca

Exploring the development and progress of BioNTech mRNA therapeutic delivery platforms
• BioNtech’s approach to mRNA therapeutic delivery
• The mRNA oncology delivery platform
• Targeting the immune system via modified mRNA-encoding antigens
• Progress in protein-based replacement therapies to treat rare disease
• Current opportunities and challenges
Heinrich Haas, VP RNA Formulation & Drug Delivery, BioNTech

Download the brochure and full programme from the event website at www.therapeutics-rna.com/EINPR3

RNA Therapeutics
Focus Day: 18th February 2020
Conference: 19th – 20th February 2020
Copthorne Tara Hotel, London, UK

Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific

— ENDS –

Contact Information:

For media enquiries contact Alia Malick on +44 (0)20 7827 6168

For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Neill Howard
SMi Group Ltd
+44 20 7827 6000
email us here


Source: EIN Presswire

World Renowned Doctor Quantifies Benefits of Alkaline Structured Silver  

Dr. Gordon Pedersen doing research In The Lab

The Silver Health Institute and formulator for My Doctor Suggests has determined that Alkaline Structured Silver has enhanced benefits over other Silvers

I am very excited about the results we achieve with the Alkaline Structured Silver, we not only see a significant difference through the data, but a physical difference in the patient performance ”

— Dr. Gordon Pedersen

SALT LAKE CITY, UTAH, USA, October 29, 2019 /EINPresswire.com/ — Dr. Gordon Pedersen, Medical Director of The Silver Health Institute and formulator for My Doctor Suggests has determined that Alkaline Structured Silver has enhanced benefits over other Silvers, that are substantiated and proven with scientific documentation.

Dr Pedersen is considered to be one of the world's leading authorities on Silver and has dedicated the past 25 years to researching the effectiveness of silver and the methods of naturally healing the body. Dr. Pedersen holds three doctor’s degrees. He has a Doctorate of Naturopathic Medicine. He has a Ph.D. from the Toxicology program at Utah State University, where he also has Ph.D. degrees in Immunology and Biology. He is Board Certified in Anti-Aging and Regenerative Medicine and also holds a Masters degree in Cardiac Rehabilitation and Wellness. He performed an internship with Jonas Salk, the American medical researcher noted for the discovery and development of the polio vaccine. He has formulated over 1500 products, was a Bronze medalist in the 2003 Utah Winter Games, and is a Best Selling Author. Dr. Gordon Pedersen has been published in numerous international peer reviewed scientific journals including the Indian Practitioner where he conducted a study that could destroy the Malaria Virus using silver.

According to Dr. Pedersen “ I am very excited about the results we achieve with the Alkaline Structured Silver, we not only see a significant difference through the data, but a physical difference in the patient performance.” Although Alkaline Structured Silver is not a cure, it has helped enhance the healing process and improved the quality of lives for those who are struggling with a variety of health challenges.

Based on the following studies, tests of silver technologies were performed at a pharmaceutical grade lab located in Salt Lake City that is FDA registered and third-party accredited to ISO 17025 standards (ACLASS). It is a GLP, GMP, and GTP facility.

This Silver Health Institute study provides primary research to answer questions frequently asked by today’s doctors as well as the general public.

The primary goal of this study was to test structured silver’s ability to kill pathogens from each of the major categories of pathogenic bacteria along with one common yeast. A secondary goal was to test the efficacy of the 2011 structured silver technology with the leading silver aquasol technology of the previous decade. This comparative test only included experimentation on two bacterial strains.

The results of this test were clear: the 2011 structured silver technology is effective with all major categories of pathogenic bacteria as well as Candida

A second study comparing silver technologies occurred in the lab at Brigham Young University in May of 2014. This study compared five silvers of vastly different concentrations and their ability to kill MRSA, a drug-resistant form of Staphylococcus. Two silvers were a 10 ppm concentration, two were 30 ppm, and one was 200 ppm. This ‘apples vs oranges’ study showed that only one of the lower-concentration silvers kept pace with silver that was 6-20 times more concentrated.

Importantly, results from this study were estimated. Quoting from the article: “Counts were so high, that the number of CFU had to be estimated on the 1:10,000 dilution of the reaction mixture. Thus, the log reduction and percent kill values are also estimates.”
That stated, here are the test results (kill rate of MRSA after 2 minutes):
1. “Solution C” (200 ppm) – 99.999955%
2. “Solution A” (30 ppm) – 99.82%
3. “Solution D” (10-30 ppm) – 58.3%
4. “Solution B” (10-30 ppm) – 47.1%
5. “Solution E” (10-30 ppm) – 39.7%
Thus, two solutions (C and A) killed nearly all of the bacteria within two minutes while three solutions (D, B and E) killed approximately half of the bacteria. The identity of the lower-concentration solutions are as follows:
Solution A: The structured silver technology developed in 2011
Solutions D, B, and E: Leading colloidal silver and silver aquasol brands
This is why structured silver is far better than just a single silver or an ionic silver or colloidal or even the hydrosols of the past. This is new and improved silver.“

Alkaline Structured Silver has been proven to have benefits for those struggling with Acid Reflux (HeartBurn), Colitis, Irritable Bowel, Diverticulitis, Digestive System, Gas / Gastritis, Genitals (Herpes, Bacteria, Fungal) Hay Fever, Immune Booster, Inflammation, Swelling, Influenza (Flu), Lyme Malaria, Parasites, Pneumonia (Bacterial, Viral) and Sore Throat along with several other health challenges. In addition to being safe for human the Alkaline structured Silver is beneficial for animals. People have used it on their horses, cats and dogs and seen amazing results.

Dr. Pedersen is a Distinguished Speaker for Special Operations Medical Association (SOMA) and has worked with several National and International governmental organizations on the topic of silver. He is also a regular keynote speaker at Anerican Naturopathic conventions. He has volunteered and personally funded efforts to bring silver’s benefits into Africa’s poorest communities with dramatic results on malaria.

For more information about Alkaline Structured Silver, Dr. Gordon Pedersen and his work go to www.mydoctorsuggests.com

Terry Warren
Global Communications Now
+1 949-743-4065
email us here

Dr. Gordon Pedersen explains the benefits of Alkaline Structured Silver


Source: EIN Presswire

ABC’s Good Day PA—Talks Regenerative Medicine with PA Green Wellness

PA Green Wellness, Offering Regenerative Medicine in Ohio, Pennsylvania and Delaware

HCTP’s Can Reverse the Cause of Pain.

HARRISBURG, PENNSYLVANIA, UNITED STATES OF AMERICA, October 29, 2019 /EINPresswire.com/ — ABC’s Good Day PA featured Dr. Magil & Jen Frey, director of Patient Services, from PA Green Wellness. Both shared how HTCP injections offer the potential to quash the cause of chronic pain.

Dr. Magil started the segment by educating the viewers that PA Green Wellness’ HCTP injections are different than most prescription medicines because they eliminate inflammation, which is the basis of all of our pain. So rather than masking the pain, this treatment eliminates it.

Good Day PA Host, Soni Dimond said, “That’s very fascinating because that’s different from what we traditionally think about medicine.” After which she asked Jen to expand on how HCTP’s help and if this is a big leap in technology.

Jen offered that HCTP refers to ‘human cell and tissue product’ which offers regenerative potential by introducing stem cells and growth factors into the body tissue. She explained, “We are born with stem cells but as we age they decline. So, with the introduction of stem cells into the body, the body will rejuvenate and reverse debilitating conditions.”

Dr. Magil shared that he has delivered over 2,000 babies throughout his career. Unfortunately, before the more recent breakthroughs within the field of regenerative medicine, the goldmine of viable stem cells in the placenta and umbilical cords (now used in HCTP treatments) were previously discarded. He said, “We weren’t educated about the life-giving potential these stem cells could offer in these procedures.”

Jen expanded further that PA Green Wellness obtains its product from Predictive Biotech, a leading FDA-registered lab located in the USA. They are ethically sourced, stand up to rigorous testing, and are meticulously handled throughout the entire process.

PA Green Wellness has witnessed some extremely promising results with their patients who’ve chosen to try HCTP injections. One of them offers her experience of rapid reduction of pain in multiple areas as well as increased energy here.

In an initial consultation, the MD driven practice does a thorough review of your medical background to see if you would have any particular contraindications, although there are not many. Most people can benefit. This simple yet powerful injection can provide some relief within days to weeks, with most reporting loss of pain, and ability to get back to the activities they love, and offering a much-improved quality of life.

PA Green Wellness invites you to join us at one of their free regenerative medicine seminars to learn more about how they can help you live your best life, free from chronic pain. You can find out when the next session is here.

PA Wellness is waiting to answer all of your questions. Visit them online at PA Green Wellness. Feel free to call and speak with one of their patient care representatives at 1-888-338-6001.

Mention Good Day PA and receive a FREE Consult!

John Cellini
PA Green Wellness
+1 888-338-6001
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Global BFSI Software Market Report 2019-2025 by Technology, Future Trends, Opportunities, Top Key Players and more…

A new market study, titled “Global BFSI Software Market Size, Status and Forecast 2019-2025”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, October 28, 2019 /EINPresswire.com/ — BFSI Software Market

BFSI software is the complete solution package that satisfies various business needs such as payment operations, commercial lending, capital market operation, customer engagement, retail & commercial banking, risk & compliance management, business intelligence, and many others in the banking and insurance sector.

This report focuses on the global BFSI Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the BFSI Software development in United States, Europe and China.

The key players covered in this study
Mindtree
SAP
IBM
Oracle
Tata
Cap Gemini
Futurism
Ramco Systems
Newgen Software
Cognizant

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4084445-global-bfsi-software-market-size-status-and-forecast-2019-2025

Market segment by Type, the product can be split into
Digital Banking
Operation
Risk & Compliance
Analytics
Others

Market segment by Application, split into
SMEs
Large enterprises

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global BFSI Software status, future forecast, growth opportunity, key market and key players.
To present the BFSI Software development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

View Detailed Report at https://www.wiseguyreports.com/reports/4084445-global-bfsi-software-market-size-status-and-forecast-2019-2025

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire

Global Internet of Things (IoT) Managed Services Market Report 2019-2025 by Technology, Trends, Top Key Players and more

A new market study, titled “Global Internet of Things (IoT) Managed Services Market Size, Status and Forecast 2019-2025”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, October 28, 2019 /EINPresswire.com/ — Internet of Things (IoT) Managed Services Market

Growing inclination toward cost-efficient managed services is expected to drive the growth of the IoT managed services market. APAC is expected to grow at the highest CAGR during the forecast period. In 2018, the global Internet of Things (IoT) Managed Services market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of % during 2019-2025.

This report focuses on the global Internet of Things (IoT) Managed Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Internet of Things (IoT) Managed Services development in United States, Europe and China.

The key players covered in this study
Cisco Systems
Cognizant Technology Solutions
Happiest Minds Technologies
Harman International Industries
Hcl Technologies
Infosys
Tata Consultancy Services
Tech Mahindra
Tieto
Virtusa
Wipro

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4059632-global-internet-of-things-iot-managed-services-market

Market segment by Type, the product can be split into
Security Management Services
Network Management Services
Data Management Services
Equipment Management Services

Market segment by Application, split into
IT
Communication
Intelligent Transportation
Smart Energy/Utilities
Smart

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Internet of Things (IoT) Managed Services status, future forecast, growth opportunity, key market and key players.
To present the Internet of Things (IoT) Managed Services development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

View Detailed Report at https://www.wiseguyreports.com/reports/4059632-global-internet-of-things-iot-managed-services-market

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
08411985042
email us here


Source: EIN Presswire